🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Sathy V. Balu‐Iyer

University at Buffalo, State University of New York

ORCID: 0000-0002-0569-2865
Immunology and MicrobiologyMedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 15 papers. Top paper: “Single-cell transcriptional analysis of murine mesenteric lymph nodes following oral lyso-phosphatidylserine nanoparticle administration reveals cellular heterogeneity in tolerance features”.

Single-cell transcriptional analysis of murine mesenteric lymph nodes following oral lyso-phosphatidylserine nanoparticle administration reveals cellular heterogeneity in tolerance features

Journal of Pharmaceutical Sciences(2025)10.1016/j.xphs.2025.103919
N/A
0.208DataRank · unranked
3 citations

Edwin J Ovalle, Jonathan Bard, Elizabeth A. Wohlfert, Jason G. Kay, Sathy V. Balu‐Iyer +1 more

Soy Phosphatidylinositol–Containing Lipid Nanoparticle Prolongs the Plasma Survival and Hemostatic Efficacy of B-domain–Deleted Recombinant Canine Factor VIII in Hemophilia A Dogs

UNC Libraries(2020)10.17615/2q5z-ke62
N/A
0DataRank · unranked
0 citations

Timothy C. Nichols, Krithika A. Shetty, Sathy V. Balu‐Iyer, Elizabeth P. Merricks, Robin A. Raymer +1 more

Immunogenicity Challenges Associated with Subcutaneous Delivery of Therapeutic Proteins

BioDrugs(2021)10.1007/s40259-020-00465-4
N/A
0DataRank · unranked
103 citations

Sathy V. Balu‐Iyer, Nicole L. Jarvi

Novel phosphatidylserine-binding molecule enhances antitumor T-cell responses by targeting immunosuppressive exosomes in human tumor microenvironments

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-003148
N/A
0DataRank · unranked
44 citations

Gautam N. Shenoy, Jenni Loyall, Brian D. Gray, Meghana V. Bapardekar, Alexis Conway +10 more

Rational design of a nanoparticle platform for oral prophylactic immunotherapy to prevent immunogenicity of therapeutic proteins

Scientific Reports(2021)10.1038/s41598-021-97333-0
N/A
0DataRank · unranked
16 citations

Fiona Glassman, Robert Dingman, Gautam N. Shenoy, Elizabeth A. Wohlfert, Jason G. Kay +3 more

Tolerogenic form of Factor VIII to prevent inhibitor development in the treatment of Hemophilia A

Journal of Thrombosis and Haemostasis(2021)10.1111/jth.15497
N/A
0DataRank · unranked
7 citations

Robert Dingman, Sathy V. Balu‐Iyer, Nhan H. Nguyen

Preclinical evaluation of cancer immune therapy using patient‐derived tumor antigen‐specific T cells in a novel xenograft platform

Clinical & Translational Immunology(2021)10.1002/cti2.1246
N/A
0DataRank · unranked
5 citations

Christopher Greene, Maulasri Bhatta, Miren L. Baroja, Jenni Loyall, Sathy V. Balu‐Iyer +6 more

Biophysical Characterization of Tolerogenic Lipid-Based Nanoparticles Containing Phosphatidylcholine and Lysophosphatidylserine

Journal of Pharmaceutical Sciences(2022)10.1016/j.xphs.2022.01.025
N/A
0DataRank · unranked
12 citations

Manlin Chen, Vincent Chak, Sathy V. Balu‐Iyer, Nhan H. Nguyen

Phosphatidylserine-mediated oral tolerance

Cellular Immunology(2022)10.1016/j.cellimm.2022.104660
N/A
0DataRank · unranked
8 citations

Vincent Chak, Katherine R. Keller, Helen Wu, Sathy V. Balu‐Iyer, Nhan H. Nguyen

A mechanistic marker-based screening tool to predict clinical immunogenicity of biologics

Communications Medicine(2023)10.1038/s43856-023-00413-7
N/A
0DataRank · unranked
15 citations

Sathy V. Balu‐Iyer, Nicole L. Jarvi

Immunogenicity of Therapeutic Biological Modalities - Lessons from Hemophilia A Therapies

Journal of Pharmaceutical Sciences(2023)10.1016/j.xphs.2023.05.014
N/A
0DataRank · unranked
7 citations

Nicole L. Jarvi, Sathy V. Balu‐Iyer, Nhan H. Nguyen

Immune regulatory adjuvant approach to mitigate subcutaneous immunogenicity of monoclonal antibodies

Frontiers in Immunology(2024)10.3389/fimmu.2024.1496169
N/A
0DataRank · unranked
3 citations

Manali I. Patel, Krithika A. Shetty, Nhan H. Nguyen, Brooke Grasperge, Donald E. Mager +3 more

Phosphatidylserine exposure on tolerogenic nanoparticle correlate with oral tolerance

Scientific Reports(2025)10.1038/s41598-025-32211-7
N/A
0DataRank · unranked
2 citations

Maya Bybel, Sujay Harne, Jason G. Kay, Elizabeth A. Wohlfert, Sathy V. Balu‐Iyer +1 more

Biological Function and Immunotherapy Utilizing Phosphatidylserine-based Nanoparticles

Immunological Investigations(2020)10.1080/08820139.2020.1738456
N/A
0DataRank · unranked
15 citations

Robert Dingman, Helena C. Yau, Sathy V. Balu‐Iyer, Fiona Glassman

Increased longevity of circulating human IgG in an NSG Fc gamma receptor-1 deficient humanized mouse model

Journal of Pharmaceutical Sciences(2025)10.1016/j.xphs.2025.103964
N/A
0DataRank · unranked
0 citations

Lisa Burzenski, Michael A. Brehm, Dale L. Greiner, Sathy V. Balu‐Iyer, Leonard D. Shultz +1 more